Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study.

Smith EA, Russell A, Lorch E, Banerjee SP, Rose M, Ivey J, Bhandari R, Moore GJ, Rosenberg DR.

Biol Psychiatry. 2003 Dec 15;54(12):1399-405.

PMID:
14675804
2.

Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder.

Fitzgerald KD, Moore GJ, Paulson LA, Stewart CM, Rosenberg DR.

Biol Psychiatry. 2000 Feb 1;47(3):174-82.

PMID:
10682215
3.

Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls.

Rosenberg DR, Mirza Y, Russell A, Tang J, Smith JM, Banerjee SP, Bhandari R, Rose M, Ivey J, Boyd C, Moore GJ.

J Am Acad Child Adolesc Psychiatry. 2004 Sep;43(9):1146-53.

PMID:
15322418
4.

Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder.

Russell A, Cortese B, Lorch E, Ivey J, Banerjee SP, Moore GJ, Rosenberg DR.

J Child Adolesc Psychopharmacol. 2003;13 Suppl 1:S31-8.

PMID:
12880498
5.

Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently.

Saxena S, Brody AL, Ho ML, Alborzian S, Ho MK, Maidment KM, Huang SC, Wu HM, Au SC, Baxter LR Jr.

Biol Psychiatry. 2001 Aug 1;50(3):159-70.

PMID:
11513814
6.

Proton magnetic resonance spectroscopic imaging in pediatric major depression.

Farchione TR, Moore GJ, Rosenberg DR.

Biol Psychiatry. 2002 Jul 15;52(2):86-92.

PMID:
12113999
7.

Effects of antidepressant treatment on N-acetyl aspartate and choline levels in the hippocampus and thalami of post-stroke depression patients: a study using (1)H magnetic resonance spectroscopy.

Huang Y, Chen W, Li Y, Wu X, Shi X, Geng D.

Psychiatry Res. 2010 Apr 30;182(1):48-52. doi: 10.1016/j.pscychresns.2009.11.009. Epub 2010 Mar 15.

PMID:
20227856
8.

A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder.

Jang JH, Kwon JS, Jang DP, Moon WJ, Lee JM, Ha TH, Chung EC, Kim IY, Kim SI.

Am J Psychiatry. 2006 Jul;163(7):1202-7.

PMID:
16816225
9.

Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine.

Gilbert AR, Moore GJ, Keshavan MS, Paulson LA, Narula V, Mac Master FP, Stewart CM, Rosenberg DR.

Arch Gen Psychiatry. 2000 May;57(5):449-56.

PMID:
10807485
10.

Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder.

Yücel M, Harrison BJ, Wood SJ, Fornito A, Wellard RM, Pujol J, Clarke K, Phillips ML, Kyrios M, Velakoulis D, Pantelis C.

Arch Gen Psychiatry. 2007 Aug;64(8):946-55.

PMID:
17679639
11.

Thalamic volume in pediatric obsessive-compulsive disorder patients before and after cognitive behavioral therapy.

Rosenberg DR, Benazon NR, Gilbert A, Sullivan A, Moore GJ.

Biol Psychiatry. 2000 Aug 15;48(4):294-300. Erratum in: Biol Psychiatry 2001 Aug 15;50(4):312.

PMID:
10960160
12.

Proton magnetic resonance spectroscopy in pediatric obsessive-compulsive disorder: longitudinal study before and after treatment.

Lázaro L, Bargalló N, Andrés S, Falcón C, Morer A, Junqué C, Castro-Fornieles J.

Psychiatry Res. 2012 Jan 30;201(1):17-24. doi: 10.1016/j.pscychresns.2011.01.017. Epub 2012 Jan 24.

PMID:
22281202
13.

Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder.

Atmaca M, Yildirim H, Ozdemir H, Koc M, Ozler S, Tezcan E.

Psychiatry Clin Neurosci. 2009 Aug;63(4):486-90. doi: 10.1111/j.1440-1819.2009.01993.x. Epub 2009 Jun 15.

14.

Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive-compulsive disorder.

Ohara K, Isoda H, Suzuki Y, Takehara Y, Ochiai M, Takeda H, Igarashi Y, Ohara K.

Psychiatry Res. 1999 Dec 20;92(2-3):83-91.

PMID:
10674362
15.

Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls.

Mirza Y, O'Neill J, Smith EA, Russell A, Smith JM, Banerjee SP, Bhandari R, Boyd C, Rose M, Ivey J, Renshaw PF, Rosenberg DR.

J Child Neurol. 2006 Feb;21(2):106-11.

PMID:
16566872
16.

Pituitary volume in pediatric obsessive-compulsive disorder.

MacMaster FP, Russell A, Mirza Y, Keshavan MS, Banerjee SP, Bhandari R, Boyd C, Lynch M, Rose M, Ivey J, Moore GJ, Rosenberg DR.

Biol Psychiatry. 2006 Feb 1;59(3):252-7. Epub 2005 Sep 2.

PMID:
16140279
17.

Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.

Yücel M, Wood SJ, Wellard RM, Harrison BJ, Fornito A, Pujol J, Velakoulis D, Pantelis C.

Aust N Z J Psychiatry. 2008 Jun;42(6):467-77. doi: 10.1080/00048670802050546.

PMID:
18465373
18.

Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine.

Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart CM, Moore GJ.

J Am Acad Child Adolesc Psychiatry. 2000 Sep;39(9):1096-103.

PMID:
10986805
19.

Differential frontal-striatal and paralimbic activity during reversal learning in major depressive disorder and obsessive-compulsive disorder.

Remijnse PL, Nielen MM, van Balkom AJ, Hendriks GJ, Hoogendijk WJ, Uylings HB, Veltman DJ.

Psychol Med. 2009 Sep;39(9):1503-18. doi: 10.1017/S0033291708005072. Epub 2009 Jan 27.

PMID:
19171077
20.

Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging.

Rosenberg DR, Amponsah A, Sullivan A, MacMillan S, Moore GJ.

J Child Neurol. 2001 Sep;16(9):636-41.

PMID:
11575601

Supplemental Content

Support Center